960 articles in this topic
Board-certified psychiatrist Dr. Paul Conti outlines practical frameworks for self-reflection, trauma healing, and overcoming self-destructive patterns.
fMRI study finds sport participation — not collision exposure — shapes neural processing in children's inhibitory control.
A memory clinic study finds 70% of patients tested positive for Alzheimer's pathology, with testing volumes exploding since new treatments arrived.
Combining polygenic and transcriptional risk scores from blood raises Alzheimer's detection accuracy, offering a less invasive screening path.
New research reveals dendrite branching is driven by random growth, with ligand contacts acting as brakes to sculpt precise neural architecture.
New research reveals microglia actively silence and reshape fear-encoding neurons during extinction learning, opening new PTSD treatment avenues.
A new NEJM case report highlights cerebral amyloid angiopathy, a vascular brain condition closely tied to cognitive decline and stroke risk.
A Cochrane review of 20,000+ patients finds amyloid-clearing drugs offer no meaningful benefit and raise brain bleed and swelling risks.
A study of 100,000 people found semaglutide users had 44% lower depression risk and 42% fewer psychiatric hospitalizations.
Cognitive reserve helps language performance early in svPPA, but accelerates decline once brain volume drops significantly.
A major Lancet review argues that optimizing current depression treatments may be more impactful than developing new ones.
A 4-protein panel in neuronal extracellular vesicles outperforms standard plasma tests in flagging early Alzheimer's brain changes.
